| Literature DB >> 31320690 |
Shota Takenaka1, Shigeyuki Kan2, Ben Seymour3,4,5, Takahiro Makino1, Yusuke Sakai1, Junichi Kushioka1, Hisashi Tanaka6, Yoshiyuki Watanabe6, Masahiko Shibata7, Hideki Yoshikawa1, Takashi Kaito8.
Abstract
Recently, there has been increasing interest in strategies to predict neurological recovery in cervical myelopathy (CM) based on clinical images of the cervical spine. In this study, we aimed to explore potential preoperative brain biomarkers that can predict postoperative neurological recovery in CM patients by using resting-state functional magnetic resonance imaging (rs-fMRI) and functional connectivity (FC) analysis. Twenty-eight patients with CM and 28 age- and sex-matched healthy controls (HCs) underwent rs-fMRI (twice for CM patients, before and six months after surgery). A seed-to-voxel analysis was performed, and the following three statistical analyses were conducted: (i) FC comparisons between preoperative CM and HC; (ii) correlation analysis between preoperative FCs and clinical scores; and (iii) postoperative FC changes in CM. Our analyses identified three FCs between the visual cortex and the right superior frontal gyrus based on the conjunction of the first two analyses [(i) and (ii)]. These FCs may act as potential biomarkers for postoperative gain in the 10-second test and might be sufficient to provide a prediction formula for potential recovery. Our findings provide preliminary evidence supporting the possibility of novel predictive measures for neurological recovery in CM using rs-fMRI.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31320690 PMCID: PMC6639260 DOI: 10.1038/s41598-019-46859-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Participant characteristics.
| Variable | CM | HC |
|---|---|---|
| Participants (n) | 28 | 28 |
| Sex (m/f) | 14/14 | 14/14 |
| Age, years | 66.5 ± 10.9 (44–79) | 66.5 ± 11.0 (43–79) |
| Handedness (right/left) | 26/2 | 26/2 |
| Medication | ||
| NSAIDs | 2 | 0 |
| Pregabalin | 3 | 0 |
| Tramadol/acetaminophen | 1 | 0 |
| Sedative-hypnotics | 7 | 0 |
| Change in the medication | 1 (Stop of pregabalin) | NA |
| Disease duration (month) | 36.4 ± 55.1 (3–246) | NA |
CM, cervical myelopathy; HC, healthy control; m, male; f, female; NSAIDs, nonsteroidal anti-inflammatory agents; NA, not applicable.
Data are presented as mean ± SD (range) for continuous variables.
Patient clinical score.
| Variable | Preop | Postop | p |
|---|---|---|---|
| JOA scores | |||
| Upper-extremity motor score | 2.2 ± 1.0 (−0.5–4) | 3.4 ± 0.6 (2.5–4) | <0.001 |
| Lower-extremity motor score | 2.3 ± 0.9 (0.5–4) | 2.9 ± 1.0 (1–4) | 0.004 |
| Upper-extremity sensory score | 1.0 ± 0.3 (0.5–1.5) | 1.3 ± 0.4 (1–2) | 0.001 |
| Trunk sensory score | 1.7 ± 0.5 (1–2) | 2.0 ± 0.1 (1.5–2) | 0.004 |
| Lower-extremity motor score | 1.2 ± 0.5 (0.5–2) | 1.7 ± 0.4 (1–2) | <0.001 |
| Sphincter score | 2.4 ± 0.7 (1–3) | 2.8 ± 0.5 (1–3) | 0.009 |
| Total | 10.8 ± 2.6 (4–15) | 14.0 ± 2.0 (9–17) | <0.001 |
| JOACMEQ scores | |||
| Neck function | 62.0 ± 27.4 (0–100) | 77.9 ± 27.6 (10–100) | 0.001 |
| Upper extremity function | 71.1 ± 25.7 (5–100) | 87.6 ± 15.7 (42–100) | 0.028 |
| Lower extremity function | 55.3 ± 29.8 (0–100) | 73.5 ± 23.1 (36–100) | 0.008 |
| Bladder function | 70.4 ± 19.0 (38–100) | 79.7 ± 17.9 (38–100) | <0.001 |
| QOL | 41.9 ± 24.0 (2–94) | 53.4 ± 21.5 (16–97) | 0.023 |
| 10-second test (lower side)* | 15.6 ± 3.5 (11–21) | 27.4 ± 7.8 (12–41) | 0.004 |
| Operative gain in 10-second test | NA | 11.8 ± 6.6 (0–21) | |
| VAS | |||
| Pain or numbness in upper extremity (mm) | 55.5 ± 28.0 (8–100) | 45.9 ± 31.3 (0–100) | 0.246 |
JOA, Japanese Orthopaedic Association; Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire; QOL, quality of life; NA, not applicable; VAS, visual analogue scale.
Data are presented as mean ± SD (range) for continuous variables.
*The number for the 10-second test was represented by that on the lower side.
Figure 1Correlation analysis between preoperative functional connectivities (FCs) and the 10-second test recovery in cervical myelopathy (CM) patients. After using the mask with CM < healthy control (HC), three visual areas (the primary visual cortex, left intracalcarine cortex, and left lingual gyrus) displayed a positive association between the 10-second test and FC with the right superior frontal gyrus. R, right; L, left.
Figure 2Result of the comparison between the pre- and postoperative cervical myelopathy (CM) groups. After using the CM < healthy control (HC) mask, the left supracalcarine cortex showed decreased connectivity with the right superior frontal gyrus. R, right; L, left.
Figure 3Correlation between postoperative gain in the 10-second test and functional connectivity strength in three visual areas (the primary visual cortex, left intracalcarine cortex, and left lingual gyrus) and the right superior frontal gyrus in patients with cervical myelopathy.